(Total Views: 53)
Posted On: 09/30/2025 9:30:47 AM
Post# of 26251
New analyst report from D. Boral Capital - NRx Re-Files ANDA for Preservative-Free IV Ketamine (KETAFREE™); Seeks Market Entry in Existing Indications
Read Report - https://ir.nrxpharma.com/static-files/76517eb...f487377cb2
#PharmaNews #MentalHealth #healthcare #ketamine #NRXPharma #HopeTherapeutics $NRXP
Read Report - https://ir.nrxpharma.com/static-files/76517eb...f487377cb2
#PharmaNews #MentalHealth #healthcare #ketamine #NRXPharma #HopeTherapeutics $NRXP